Live Breaking News & Updates on Immunovia Dx Laboratory In Marlborough

Stay updated with breaking news from Immunovia dx laboratory in marlborough. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Immunovia Reports Interim Report January


Following the telephone conference, a recording will be available on Immunovia s website (www.immunovia.com).
For more information, please contact:
Patrik Dahlen, CEO Immunovia
Tel: +46 73 376 76 64
This is information that Immunovia is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 16.00 CET on April 28, 2021.
About Immunovia
Immunovia AB is a diagnostic company that is developing and commercializing highly accurate blood tests for the early detection of cancer and autoimmune diseases based on Immunovia s proprietary test platform called IMMray™. Tests are based on antibody biomarker microarray analysis using advanced machine-learning and bioinformatics to single-out a set of relevant biomarkers that indicate a certain disease. Thus, forming a unique disease biomarker signature . ....

United States , United Kingdom , Prnewswire Immunovia , Patrik Dahlen , Immunovia Dx Laboratory In Marlborough , Department Of Immuntechnology At Lund University , Health Cancer Center , Lund University , Cancer Center , Immunovia Dx Laboratory , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , பற்றிக் டஹ்லன் , ஆரோக்கியம் புற்றுநோய் மையம் , லண்ட் பல்கலைக்கழகம் , புற்றுநோய் மையம் ,